Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evommune (EVMN) Operating Leases (2025)

Evommune (EVMN) has disclosed Operating Leases for 1 consecutive years, with $1.3 million as the latest value for Q4 2025.

  • Quarterly Operating Leases changed N/A to $1.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.3 million through Dec 2025, changed N/A year-over-year, with the annual reading at $1.3 million for FY2025, N/A changed from the prior year.
  • Operating Leases for Q4 2025 was $1.3 million at Evommune.
  • The five-year high for Operating Leases was $1.3 million in Q4 2025, with the low at $1.3 million in Q4 2025.